|
🐜
|
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.
24 auth.
P. Poortmans,
S. Collette,
C. Kirkove,
E. van Limbergen,
V. Budach,
H. Struikmans,
L. Collette,
A. Fourquet,
P. Maingon,
M. Valli,
...
K. D. de Winter,
S. Marnitz,
I. Barillot,
L. Scandolaro,
E. Vonk,
C. Rodenhuis,
H. Marsiglia,
N. Weidner,
G. van Tienhoven,
C. Glanzmann,
A. Kuten,
R. Arriagada,
H. Bartelink,
W. van den Bogaert
|
9 |
2015 |
9
🐜
|
|
🐜
|
Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients.
20 auth.
M. Ozsahin,
R. Tsang,
P. Poortmans,
Y. Belkacemi,
M. Bolla,
F. Dincbas,
C. Landmann,
B. Castelain,
J. Buijsen,
J. Curschmann,
...
S. Kadish,
A. Kowalczyk,
Y. Anacak,
J. Hammer,
T. Nguyen,
G. Studer,
R. Cooper,
M. Şengöz,
L. Scandolaro,
A. Zouhair
|
7 |
2006 |
7
🐜
|
|
🐜
|
Phyllodes tumor of the breast.
16 auth.
Y. Belkacemi,
G. Bousquet,
H. Marsiglia,
I. Ray-Coquard,
N. Magné,
Y. Malard,
M. Lacroix,
C. Gutiérrez,
Elżbieta Senkus,
D. Christie,
...
K. Drumea,
E. Lagneau,
S. Kadish,
L. Scandolaro,
D. Azria,
M. Ozsahin
|
7 |
2008 |
7
🐜
|
|
🐜
|
Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy.
15 auth.
S. Martinet,
M. Ozsahin,
Y. Belkacemi,
C. Landmann,
P. Poortmans,
Christoph Oehlere,
L. Scandolaro,
M. Krengli,
P. Maingon,
R. Miralbell,
...
G. Studer,
B. Chauvet,
S. Marnitz,
A. Zouhair,
R. Mirimanoff
|
7 |
2003 |
7
🐜
|
|
🐜
|
Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network.
20 auth.
A. Omlin,
M. Amichetti,
D. Azria,
B. Cole,
P. Fourneret,
P. Poortmans,
D. Naehrig,
RobertI Miller,
M. Krengli,
C. Gutiérrez Miguélez,
...
D. Morgan,
H. Goldberg,
L. Scandolaro,
P. Gastelblum,
M. Ozsahin,
D. Dohr,
D. Christie,
U. Oppitz,
U. Abacioglu,
G. Gruber
|
7 |
2006 |
7
🐜
|
|
🐜
|
Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles.
9 auth.
L. F. Cazzaniga,
M. Marinoni,
A. Bossi,
E. Bianchi,
E. Cagna,
D. Cosentino,
...
L. Scandolaro,
Marica Valli,
M. Frigerio
|
6 |
1998 |
6
🐜
|
|
🐜
|
Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer Network.
14 auth.
Y. Belkacemi,
C. Berger,
P. Poortmans,
G. Piel,
A. Zouhair,
J. Méric,
T. Nguyen,
M. Krengli,
F. Behrensmeier,
A. Allal,
...
D. de Looze,
J. Bernier,
L. Scandolaro,
R. Mirimanoff
|
6 |
2003 |
6
🐜
|
|
🐜
|
Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study.
18 auth.
E. Ozyar,
U. Selek,
S. Laskar,
O. Uzel,
Y. Anacak,
M. Ben-Arush,
S. Polychronopoulou,
F. Akman,
S. Wolden,
S. Sarıhan,
...
RobertI Miller,
M. Ozsahin,
U. Abacioglu,
Margarita Martín,
M. Caloglu,
L. Scandolaro,
E. Szutowicz,
I. Atahan
|
6 |
2006 |
6
🐜
|
|
🐜
|
Primary spinal epidural lymphoma: patients' profile, outcome, and prognostic factors: a multicenter Rare Cancer Network study.
12 auth.
V. Monnard,
A. Sun,
R. Epelbaum,
P. Poortmans,
RobertI Miller,
T. Verschueren,
...
L. Scandolaro,
S. Villà,
S. B. Majno,
Sandrine Ostermann,
M. Ozsahin,
R. Mirimanoff
|
6 |
2006 |
6
🐜
|
|
🐜
|
The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer Network.
20 auth.
P. Ghadjar,
J. Kaanders,
P. Poortmans,
R. Zaucha,
M. Krengli,
J. Lagrange,
O. Özsoy,
T. Nguyen,
R. Miralbell,
A. Baize,
...
N. Boujelbene,
T. Collen,
L. Scandolaro,
M. Untereiner,
H. Goldberg,
G. Pesce,
Y. Anacak,
E. Friedrich,
D. Aebersold,
K. Beer
|
6 |
2011 |
6
🐜
|
